Separate promising research from proven care.
posted on
By the Regenerative Evidence Guide Team A Data and Safety Monitoring Board (DSMB) is an independent group of outside experts who periodically review a clinical trial's accumulating data while the …
Continue Reading about Data and Safety Monitoring in Research: What a DSMB Does →
posted on
By the Regenerative Evidence Guide Team What "Eligibility Criteria" Means Every public clinical trial record lists eligibility criteria — the requirements researchers use to decide who can join a …
posted on
By the Regenerative Evidence Guide Team Clinical trial status labels describe where a study sits in its enrollment timeline, not whether the treatment works. "Recruiting" means the study is currently …
Continue Reading about Clinical Trial Status Labels Explained: Recruiting, Active, and Completed →
posted on
By the Regenerative Evidence Guide Team What Is a Study Protocol vs. a Study Result? A study protocol is the written plan for a clinical trial — what will be tested, on whom, and how the outcome will …
Continue Reading about A Study Protocol and a Study Result: Why the Difference Matters →
posted on
By the Regenerative Evidence Guide Team What do randomization, blinding, and placebo mean in a study? Randomization means participants are assigned to a treatment or comparison group by chance, not …
Continue Reading about Randomization, Blinding, and Placebos: What Research Design Terms Mean →
posted on
By the Regenerative Evidence Guide Team A study endpoint is the specific result a research team plans, before a study begins, to measure and report as its main finding. Clinical studies register these …
Continue Reading about Study Endpoints Explained: What Researchers Plan to Measure →